TNFRSF19 and gastric cancer: Nevertheless, Wilhelm et al.[28] evaluated the expression of TROY in GC patients by immunohistochemistry and qRT-PCR and demonstrated its loss of expression in tumor tissue, as well as loss of colony formation ability in a TROY-over-expressing GC cell line.